Mental Health Commission

Office of Alcohol and Other Drugs

On 1 July 2024, the Mental Health Commission (Commission) launched its dedicated Office of Alcohol and Other Drugs (the Office) to strengthen and elevate alcohol and other drugs governance in Western Australia.

Two staff discussing the purpose of the Office of Alcohol and Other Drugs.

Purpose 

The Office is responsible for informing, developing, and overseeing the State Government’s alcohol and other drugs strategy and system-wide strategic policy reform. It drives interagency coordination and strengthens intergovernmental and sector-wide relationships to achieve better outcomes for the Western Australian community.

Commitment to reform

Following the findings from the Independent Review of the Health Services Act 2016, an Alcohol and Other Drugs Governance Working Group (the Working Group) was convened in October 2023 to inform optimal governance arrangements. Membership consisted of peak body, sector and consumer representatives, and representatives from the Commission and Department of Health. 

The Working Group considered strategies to elevate alcohol and other drugs aligned to an agreed set of guiding principles which reflected the desired future state of alcohol and other drugs governance in Western Australia. 

In 2024, the State Government announced a package of reforms to strengthen leadership, accountability and collaboration to accelerate and sustain action to prevent and reduce harms from alcohol and other drugs in the Western Australian community.

Based on the Working Group’s guidance, the Strengthening Alcohol and Other Drugs Governance in Western Australia Implementation Plan was developed and released in May 2024, outlining the Commission’s plan to deliver on the guiding principles in partnership with key stakeholders.

Driven by the Office, progress against the Implementation Plan is reported annually and reflects collective action by the Commission and other key government and non-government partners to elevate the focus on alcohol and other drugs.

Read the Implementation Plan 

Read the Annual Progress Report – 1 July 2024 to 30 June 2025

Page last updated22 December 2025

Back to Top of the page